Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price shot up 21.2% during mid-day trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. 292,294 shares were traded during mid-day trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The company has a market capitalization of C$25.10 million, a price-to-earnings ratio of -18.00 and a beta of 0.32. The stock has a 50-day moving average price of C$0.11 and a 200-day moving average price of C$0.08.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- Using the MarketBeat Stock Split Calculator
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Stock Analyst Ratings and Canadian Analyst Ratings
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Quiet Period Expirations Explained
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
